CoupledCAR Platform Pipeline

Robust pipeline addressing large solid tumor markets with high unmet medical need

• Rapid proof of concept (PoC) and clinical data from China IRB-approved trials
• US clinical trials gain insights from preliminary IRB trial validation
• Extensive pipeline in development, with multiple China-based IRB trials recruiting participants